Scientific Games Corporation Profile Avatar - Palmy Investing

Scientific Games Corporation

Scientific Games Corporation, doing business as Light & Wonder Inc., develops technology-based products and services, and related content for the gaming, lottery, social and digital gaming industries in the United States and internationally. The company'…
Gambling, Resorts & Casinos
US, Las Vegas [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 14% Weak
Profitability n.A. n.A.
Fin. Growth 50% Balanced
Leverage & Liquidity 17% Weak
Per Share Metrics 0% Bad
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA -36.10 55.64 87.07
Graham Fair Price -45.46 11.93 21.87
PEG -110.50 -0.75 -0.35
Price/Book 19.12 -2.49 -3.08
Price/Cash Flow 198.20 111.74 37.47
Prices/Earnings 221.21 54.80 17.06
Price/Sales -10.86 9.96 11.18
Price/FCF 198.20 111.74 37.47
Naive Interpretation member
01 - Valuation · Weak
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin 1.89 0.72 0.71
Operating Margin 913.99 0.07 < 0.005
ROA -72.87 < 0.005 0.01
ROE -0.05 -0.01 74.82
ROIC < 0.005 < 0.005 1395.31
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ 0.02 -0.02 -4.28
Dividends QOQ 0.00 0.00 0.00
EBIT QOQ -0.88 9.00 920.00
EPS QOQ -0.48 -0.73 -52.59
FCF QOQ < 0.005 -0.71 12029.48
Revenue QOQ 0.08 -0.01 -81.87
Naive Interpretation member
03 - Financial Growth · Balanced
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 51.88 63.56 22.51
Days Sales Outstanding (DSO) 266.20 275.03 3.32
Inventory Turnover 1.73 1.42 -18.38
Debt/Capitalization 1.32 1.35 2.26
Quick Ratio 1.03 1.00 -3.37
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value -21.71 -23.60 -8.69
Cash 6.03 5.11 -15.21
Capex -0.55 -0.44 18.87
Free Cash Flow 1.78 0.53 -70.52
Revenue 5.98 5.90 -1.38
Naive Interpretation member
05 - Per Share Metrics · Bad
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 1.78 1.89 6.53
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 48.48 33.11 -31.71
Naive Interpretation Member
06 - Financial Health · Weak
End of SGMS's Analysis
CIK: 750004 CUSIP: 80874P109 ISIN: US80874P1093 LEI: - UEI: -
Secondary Listings
SGMS has no secondary listings inside our databases.